Fact CheckerSign in

NCT07412028Recruiting

Identification of Women With Severe Insulin Resistant Syndromes of Genetic Origin Among Patients With "Classic" Polycystic Ovary Syndrome (PCOS)

Source: ClinicalTrials.gov · Last updated 10 Aug 2026

Brief summary (registry, in English)

Diagnostic case-control study (1 case for 2 controls). Inclusion of patients with severe insulin resistance syndrome of genetic origin, then inclusion of controls: patients examined for PCOS in day hospital with matching age (+/- 5 years) and Body mass index (+/- 5kg/m2).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
81 (estimated)
First submitted
27 Jan 2026
Start date
21 Jul 2026
Primary completion date
Jan 2028
Lead sponsor
Assistance Publique - Hôpitaux de Paris
NCT number
NCT07412028

What you commit to

  • Study type: Interventional
  • Planned participants: 81
  • From 21 Jul 2026 to the primary completion date, Jan 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Taking corticosteroids or antiretrovirals ;
  • Taking estrogen-progestin therapy;

Other illness

  • Hepato-cellular insufficiency (TP \< 50%) ;
  • Diabetic patients on insulin : type 1 diabetes or pancreatectomised patients
  • Other known causes of hyperandrogenism (21-hydroxylase block, Cushing's syndrome, ovarian tumor).

Lab values

  • \- Severe renal insufficiency (GFR \< 30 ml/min) ;

Other

  • Menopausal women ;
  • Pregnant woman
  • Breastfeeding woman

Who the study is looking for

  • Women aged ≥ 18 years and \< 45 years ;
  • Discontinuation of estrogen-progestin therapyfor at least 3 months ;
  • Signed informed consent ;
  • Social security affiliation.
    • Case (n=25):
    • \- Patient with a lipodystrophic syndrome due to a known pathogenic variant of the LMNA gene.
    • Control (n=50), :
    • \- patient consulting for polycystic ovary syndrome (PCOS according to the Rotterdam criteria) in day hospital matched on age +/-5 years and BMI+/-5 kg/m2.

Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Service Endocrinologie, Hôpital St Antoine
Coordinator of this site? Confirm its status
ParisFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.